Effect of Imatinib in Advance Liver Fibrosis Patients
Clinical trial NCT05224128 · UNKNOWN
Trial details
- NCT number
- NCT05224128
- Sponsor
- Research Institute for Gastroenterology and Liver Diseases (RIGLD)
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-20
- Primary completion
- 2022-02-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.